TY - JOUR AU - Qian, X. AU - Liu, J. AU - Sun, Y. PY - 2016 DA - 2016// TI - Circulating cell-free DNA has a high degree of specifcity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer JO - Oncotarget VL - 7 ID - Qian2016 ER - TY - JOUR AU - Veldore, V. H. AU - Choughule, A. AU - Routhu, T. PY - 2018 DA - 2018// TI - Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer JO - Lung Cancer VL - 9 ID - Veldore2018 ER - TY - JOUR AU - Paweletz, C. P. AU - Sacher, A. G. AU - Raymond, C. K. PY - 2016 DA - 2016// TI - Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients JO - Clin Cancer Res VL - 22 ID - Paweletz2016 ER - TY - JOUR AU - Newman, A. M. AU - Lovejoy, A. F. AU - Klass, D. M. PY - 2016 DA - 2016// TI - Integrated digital error suppression for improved detection of circulating tumor DNA JO - Nat Biotechnol VL - 34 ID - Newman2016 ER - TY - JOUR AU - Lee, J. Y. AU - Qing, X. AU - Xiumin, W. PY - 2016 DA - 2016// TI - Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean lung cancer consortium (KLCC-12-02) JO - Oncotarget. VL - 7 ID - Lee2016 ER - TY - JOUR AU - Sacher, A. G. AU - Paweletz, C. AU - Dahlberg, S. E. PY - 2016 DA - 2016// TI - Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer JO - JAMA Oncol VL - 2 ID - Sacher2016 ER - TY - JOUR AU - Trigg, R. M. AU - Martinson, L. J. AU - Parpart-Li, S. AU - Shaw, J. A. PY - 2018 DA - 2018// TI - Factors that influence quality and yield of circulating-free DNA: a systematic review of the methodology literature JO - Heliyon VL - 4 ID - Trigg2018 ER - TY - JOUR AU - Dessel, L. F. AU - Vitale, S. R. AU - Helmijr, J. C. A. PY - 2019 DA - 2019// TI - High-throughput isolation of circulating tumor DNA: a comparison of automated platforms JO - Mol Oncol VL - 13 ID - Dessel2019 ER - TY - JOUR AU - Nakashima, C. AU - Sato, A. AU - Abe, T. PY - 2018 DA - 2018// TI - Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments JO - Oncotarget VL - 9 ID - Nakashima2018 ER - TY - JOUR AU - Phan, T. T. AU - Tran, B. T. AU - Nguyen, S. T. PY - 2019 DA - 2019// TI - EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer JO - Clin Trans Med VL - 8 ID - Phan2019 ER - TY - JOUR AU - McHugh, M. L. PY - 2012 DA - 2012// TI - Interrater reliability: the kappa statistic JO - Biochem Med VL - 22 ID - McHugh2012 ER - TY - JOUR AU - Siravegna, G. AU - Marsoni, S. AU - Siena, S. AU - Bardelli, A. PY - 2017 DA - 2017// TI - Integrating liquid biopsies into the management of cancer JO - Nat Rev Clin Oncol VL - 14 ID - Siravegna2017 ER - TY - JOUR AU - Rapisuwon, S. AU - Vietsch, E. E. AU - Wellstein, A. PY - 2016 DA - 2016// TI - Circulating biomarkers to monitor cancer progression and treatment JO - Comput Struct Biotechnol J VL - 14 ID - Rapisuwon2016 ER - TY - JOUR AU - Goto, K. AU - Ichinose, Y. AU - Ohe, Y. PY - 2012 DA - 2012// TI - Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer JO - J Thorac Oncol VL - 7 ID - Goto2012 ER - TY - JOUR AU - Xu, F. AU - Wu, J. AU - Xue, C. PY - 2012 DA - 2012// TI - Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib JO - Onco Targets Ther VL - 5 ID - Xu2012 ER - TY - JOUR AU - Li, X. AU - Ren, R. AU - Ren, S. PY - 2014 DA - 2014// TI - Peripheral blood for epidermal growth factor receptor mutation detection in non-small cell lung cancer patients JO - Transl Oncol VL - 7 ID - Li2014 ER - TY - JOUR AU - Xu, H. AU - Baidoo, A. A. AU - Su, S. PY - 2019 DA - 2019// TI - A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients JO - Transl Lung Cancer Res VL - 8 ID - Xu2019 ER - TY - JOUR AU - Ma, M. AU - Shi, C. AU - Qian, J. PY - 2016 DA - 2016// TI - Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced nonsmall cell lung cancer JO - Gene VL - 591 ID - Ma2016 ER - TY - JOUR AU - Joshi, J. AU - Raval, A. AU - Desai, U. PY - 2019 DA - 2019// TI - EGFR mutation analysis in non-small cell lung carcinoma patients: a liquid biopsy approach JO - Ind J Clin Biochem UR - https://doi.org/10.1007/s12291-019-00864-7 DO - 10.1007/s12291-019-00864-7 ID - Joshi2019 ER - TY - JOUR AU - Wu, Y. L. AU - Sequist, L. V. AU - Hu, C. P. PY - 2017 DA - 2017// TI - EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6 JO - Br J Cancer VL - 116 ID - Wu2017 ER - TY - JOUR AU - Denis, M. G. AU - Lafourcade, M. P. AU - Garff, G. L. PY - 2019 DA - 2019// TI - Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study JO - J Thorac Dis VL - 11 ID - Denis2019 ER - TY - JOUR AU - Douillard, J. Y. AU - Ostoros, G. AU - Cobo, M. PY - 2014 DA - 2014// TI - Gefitinib treatment in EGFR mutated caucasian NSCLC circulating free tumor DNA as a surrogate for determination of EGFR status JO - J Thorac Oncol VL - 9 ID - Douillard2014 ER - TY - JOUR AU - Soria-Comes, T. AU - Palomar-Abril, V. AU - Ureste, M. M. PY - 2020 DA - 2020// TI - Real-world data of the correlation between EGFR determination by liquid biopsy in non-squamous non-small cell lung cancer (NSCLC) and the EGFR profile in tumor biopsy JO - Pathol Oncol Res VL - 26 ID - Soria-Comes2020 ER - TY - JOUR AU - Wu, Y. L. AU - Lee, V. AU - Liam, C. K. PY - 2018 DA - 2018// TI - Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies JO - Lung Cancer VL - 26 ID - Wu2018 ER - TY - JOUR AU - Feng, W. AU - Gu, W. AU - Zhao, N. PY - 2018 DA - 2018// TI - Comparison of the SuperARMS and droplet digital PCR for detecting EGFR mutation in ctDNA from NSCLC patients JO - Transl Oncol VL - 11 ID - Feng2018 ER - TY - JOUR AU - Li, Y. AU - Xu, H. AU - Su, S. PY - 2017 DA - 2017// TI - Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma JO - PLoS ONE VL - 12 ID - Li2017 ER - TY - JOUR AU - Wang, L. AU - Guo, Q. AU - Yu, W. PY - 2017 DA - 2017// TI - Quantification of plasma EGFR mutations in patients with lung cancers: comparison of the performance of ARMS-Plus and droplet digital PCR JO - Lung Cancer VL - 114 ID - Wang2017 ER - TY - JOUR AU - Zhang, X. AU - Chang, N. AU - Yang, G. PY - 2017 DA - 2017// TI - A comparison of ARMS-Plus and droplet digital PCR for detecting EGFR activating mutations in plasma JO - Oncotarget VL - 8 ID - Zhang2017 ER - TY - JOUR AU - Yung, T. K. AU - Chan, K. C. AU - Mok, T. S. PY - 2009 DA - 2009// TI - Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients JO - Clin Cancer Res VL - 15 ID - Yung2009 ER - TY - JOUR AU - Reckamp, K. L. AU - Melnikova, V. O. AU - Karlovich, C. PY - 2016 DA - 2016// TI - A Highly sensitive and quantitative test 30.platform for detection of NSCLC EGFR mutations in urine and plasma JO - J Thorac Oncol VL - 11 ID - Reckamp2016 ER - TY - JOUR AU - Guo, N. AU - Lou, F. AU - Ma, Y. PY - 2016 DA - 2016// TI - Circulating tumor DNA detection in lung cancer patients before and after surgery JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep33519 DO - 10.1038/srep33519 ID - Guo2016 ER - TY - JOUR AU - Mok, T. AU - Wu, Y. L. AU - Lee, J. S. PY - 2015 DA - 2015// TI - Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy JO - Clin Cancer Res VL - 21 ID - Mok2015 ER - TY - JOUR AU - Taniguchi, K. AU - Okami, J. AU - Kodama, K. PY - 2008 DA - 2008// TI - Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib JO - Cancer Sci VL - 99 ID - Taniguchi2008 ER - TY - JOUR AU - Bai, H. AU - Wang, Z. AU - Chen, K. PY - 2012 DA - 2012// TI - Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer JO - J Clin Oncol VL - 30 ID - Bai2012 ER - TY - JOUR AU - Zhang, S. AU - Zhu, L. AU - Chen, X. PY - 2018 DA - 2018// TI - ctDNA assessment of EGFR mutation status in Chinese patients with advanced non-small cell lung cancer in real-world setting JO - J Thorac Dis VL - 10 ID - Zhang2018 ER - TY - JOUR AU - Zhang, Y. L. AU - Yuan, J. Q. AU - Wang, K. F. PY - 2016 DA - 2016// TI - The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis JO - Oncotarget VL - 7 ID - Zhang2016 ER - TY - JOUR AU - Alexandrov, L. B. AU - Ju, Y. S. AU - Haase, K. PY - 2016 DA - 2016// TI - Mutational signatures associated with tobacco smoking in human cancer JO - Science VL - 354 ID - Alexandrov2016 ER - TY - JOUR AU - Nagahashi, M. AU - Sato, S. AU - Yuza, K. PY - 2018 DA - 2018// TI - Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma JO - J Surg Res VL - 230 ID - Nagahashi2018 ER - TY - JOUR AU - Chae, Y. K. AU - Davis, A. A. AU - Agte, S. PY - 2019 DA - 2019// TI - Clinical implications of circulating tumor DNA tumor mutational burden (ctDNA TMB) in non-small cell lung cancer JO - Oncologist VL - 24 ID - Chae2019 ER - TY - JOUR AU - Yu, X. J. AU - Chen, G. AU - Yang, J. PY - 2019 DA - 2019// TI - Smoking alters the evolutionary trajectory of non–small cell lung cancer JO - Exp Ther Med VL - 18 ID - Yu2019 ER - TY - JOUR AU - Willis, C. AU - Fiander, M. AU - Tran, D. PY - 2019 DA - 2019// TI - Tumor mutational burden in lung cancer: a systematic literature review JO - Oncotarget VL - 10 ID - Willis2019 ER - TY - JOUR AU - Subramanian, J. AU - Govindan, R. PY - 2008 DA - 2008// TI - Molecular genetics of lung cancer in people who have never smoked JO - Lancet Oncol VL - 9 ID - Subramanian2008 ER - TY - JOUR AU - Liu, X. AU - Lin, X. J. AU - Wang, C. P. PY - 2014 DA - 2014// TI - Association between smoking and p53 mutation in lung cancer: a meta-analysis JO - Clin Oncol VL - 26 ID - Liu2014 ER - TY - JOUR AU - Chapman, A. M. AU - Sun, K. Y. AU - Ruestow, P. AU - Cowan, D. M. AU - Madl, A. K. PY - 2016 DA - 2016// TI - Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers JO - Lung Cancer VL - 102 ID - Chapman2016 ER -